A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination therapy in Subjects with Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
- Keating, Dominic (Primary Chief Investigator (PCI))
- Wilson, John (Chief Investigator (CI))
Project: Research